Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
Several Alliance medical specialty societies wrote to CMS Administrator Tavenner to express concerns with the proposed rule that would modify aspects of the Medicare Advantage and
Part D prescription drug program to the detriment of beneficiaries.
